Aggressive Infliximab Dosing Shows No Added Benefit in UC ...Middle East

Medscape - News
Aggressive infliximab dosing did not provide additional clinical benefits for patients with steroid-refractory acute severe ulcerative colitis compared with standard dosing. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Aggressive Infliximab Dosing Shows No Added Benefit in UC )

Also on site :

Most viewed in News